Coalition for the Reversal of Breast Cancer Mortality in African American Women

A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond

Showing posts with label rituxan. Show all posts
Showing posts with label rituxan. Show all posts
Wednesday, December 18, 2013

Proof that target therapy has come in to change things in cancers!

›
1.Combining Ibrutinib with R-CHOP is not only feasible but yield 100% response in Diffuse Large cell Lymphoma. For decades, CHOP had remai...
Wednesday, March 6, 2013

Mantle Cell Lymphoma

›
*In Mantle cell lymphoma, Rituxan-Bendamustine beats R-CHOP with progression  free survival of 69 months vs 31 months and with better toxic...
Friday, February 8, 2013

SUGGESTION OF TREATMENT OPTIONS IN PATIENTS WITH ACTIVATED B CELL LYMPHOMA AFTER FAILURE OF R-CHOP IF PATIENT IS A POOR CANDIDATE

›
IN Not transplant candidates: The options are: 1.Revlimid+ Rituxan 2.Rev+RICE is being trial 3.Reduced Conditioning Allogeneic Transpla...
Friday, January 18, 2013

TALKING DE-ACETYLATION, PANOBINOSTAT

›
Panobinostat is a De-acetylator inhibitor for Histone, meaning that it paralyzes a few enzymes perinuclearly, therefore blocking Mitosis thi...
›
Home
View web version

Steering Committee

Peggy Kankonde
View my complete profile
Powered by Blogger.